ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
0,19
-0,0011
(-0,58%)
Geschlossen 21 Dezember 10:00PM
0,1962
0,0062
(3,26%)
Nach Börsenschluss: 1:42AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,1962
Gebot
-
Fragen
-
Volumen
344.242
0,1852 Tagesbereich 0,199
0,1628 52-Wochen-Bereich 0,62
Marktkapitalisierung
Handelsende
0,1911
Handelsbeginn
0,1892
Letzte Trade
50108
@
0.19
Letzter Handelszeitpunkt
Finanzvolumen
US$ 66.719
VWAP
0,193813
Durchschnittliches Volumen (3 Mio.)
445.205
Ausgegebene Aktien
63.706.446
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,96
Gewinn pro Aktie (EPS)
-0,45
Erlöse
202k
Nettogewinn
-28,96M

Über AIM ImmunoTech Inc

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
AIM ImmunoTech Inc is listed in the Biological Pds,ex Diagnstics sector of the Amerikanische Börse with ticker AIM. The last closing price for AIM ImmunoTech was US$0,19. Over the last year, AIM ImmunoTech shares have traded in a share price range of US$ 0,1628 to US$ 0,62.

AIM ImmunoTech currently has 63.706.446 shares in issue. The market capitalisation of AIM ImmunoTech is US$12,17 million. AIM ImmunoTech has a price to earnings ratio (PE ratio) of -3.96.

AIM Neueste Nachrichten

AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that it received a notice (the “Notice”) from the NYSE American...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0167-7.844058243310.21290.2250.18654362780.20202945CS
4-0.0155-7.321681624940.21170.2440.18653737710.2115237CS
12-0.0838-29.92857142860.280.2890.16284452050.22550803CS
26-0.1938-49.69230769230.390.42950.16283494660.26777379CS
52-0.3028-60.68136272550.4990.620.16282909360.33255823CS
156-0.9438-82.78947368421.141.380.16282372990.60404884CS
260-0.2619-57.17092337920.45818.750.162813560262.49002481CS

AIM - Frequently Asked Questions (FAQ)

What is the current AIM ImmunoTech share price?
The current share price of AIM ImmunoTech is US$ 0,1962
How many AIM ImmunoTech shares are in issue?
AIM ImmunoTech has 63.706.446 shares in issue
What is the market cap of AIM ImmunoTech?
The market capitalisation of AIM ImmunoTech is USD 12,17M
What is the 1 year trading range for AIM ImmunoTech share price?
AIM ImmunoTech has traded in the range of US$ 0,1628 to US$ 0,62 during the past year
What is the PE ratio of AIM ImmunoTech?
The price to earnings ratio of AIM ImmunoTech is -3,96
What is the cash to sales ratio of AIM ImmunoTech?
The cash to sales ratio of AIM ImmunoTech is 562,5
What is the reporting currency for AIM ImmunoTech?
AIM ImmunoTech reports financial results in USD
What is the latest annual turnover for AIM ImmunoTech?
The latest annual turnover of AIM ImmunoTech is USD 202k
What is the latest annual profit for AIM ImmunoTech?
The latest annual profit of AIM ImmunoTech is USD -28,96M
What is the registered address of AIM ImmunoTech?
The registered address for AIM ImmunoTech is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the AIM ImmunoTech website address?
The website address for AIM ImmunoTech is www.aimimmuno.com
Which industry sector does AIM ImmunoTech operate in?
AIM ImmunoTech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGLDMarygold Companies Inc
US$ 2,053
(48,77%)
128,45k
MINFT Limited
US$ 7,25
(44,22%)
948,89k
CTMCastellum Inc
US$ 0,578
(41,01%)
8,94M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 12,49
(22,81%)
64,96M
BATLBattalion Oil Corporation
US$ 1,3499
(-44,56%)
1,63M
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 11,5991
(-35,47%)
407,1k
UVIX2x Long VIX Futures ETF
US$ 3,83
(-29,07%)
70,61M
TPETTrio Petroleum Corp
US$ 1,10
(-25,17%)
2,81M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 19,235
(-23,06%)
21,33M
SPYSPDR S&P 500
US$ 591,15
(0,86%)
122,49M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,1628
(-3,25%)
114,87M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,30
(3,80%)
108,08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,435
(7,27%)
94,23M
KULRKULR Technology Group Inc
US$ 2,885
(28,79%)
75,72M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock